Registry of Lobbyists
| Registrant name: | Summer Senter |
| Client: | Optimind Pharma |
| Associated registration: | 944041-370665-1 |
| Communication date: | 2022-04-19 |
| Posted date: | 2022-05-02 |
| Designated Public Office Holders who participated in the communication: |
Paul Smeaton,
Manager of the Quality Division
Office of Clinical Trials, Health Canada (HC) Jennifer Pelley, Director, Office of Legislative and Regulatory Affairs Health Canada (HC) Carole Légaré, Director, Office of Clinical Trials Health Canada (HC) Larissa Lefebvre, Manager, Submissions Management Division Office of Clinical Trials, Health Canada (HC) Daniel Keene, Associate Director, Office of Clinical Trials Health Canada (HC) Aqsa Malik, Senior Policy Analyst Office of Legislative and Regulatory Affairs, Health Canada (HC) Carol Anne Chénard, Director, Office of Controlled Substances Health Canada (HC) |
| Subject Matter of the communication: | Health |